Skip to content
value.today

Johnson & Johnson vs ProPhase Labs, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $87 M for ProPhase Labs, Inc., 7500 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Johnson & Johnson had more revenue: $94.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025.
  • Johnson & Johnson made a net profit of $26.8 B, while ProPhase Labs, Inc. made a net loss of $15 M.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -339.6% for ProPhase Labs, Inc.
  • Johnson & Johnson employs more people: 138,200 against 19 at ProPhase Labs, Inc. Each employee brings in about $681,570 of revenue at Johnson & Johnson and $228,421 at ProPhase Labs, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01773555327092020202120222023202420252026Johnson & Johnson 170ProPhase Labs, Inc. 395

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B201720182019202020212022202320242025Johnson & Johnson $94BProPhase Labs, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureJohnson & Johnson
JNJ · #23 in the world
ProPhase Labs, Inc.
PRPH
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded18861989
Size
Market cap$652.5 B$87 M*
Revenue$94.2 B$4 M
Net income$26.8 B▲ best$-15 M
Employees138,20019
Valuation
P/E ratio40.5×—
Price to sales6.6×—
Price to book8.0×—
Free cash flow yield3.0%—
Profitability
Gross margin—31.8%
Operating margin—-415.9%
Net margin—-339.6%
Return on equity—-271.4%
Growth
Revenue growth—-35.9%
Revenue growth, 3 years a year—-67.2%
Financial strength
Interest cover—-2.6×
Cash
Free cash flow margin—-192.2%
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Jan 2024; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Johnson & Johnson or ProPhase Labs, Inc.?

Johnson & Johnson is the larger company by market value: $652.5 B against $87 M for ProPhase Labs, Inc., 7500 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Johnson & Johnson or ProPhase Labs, Inc.?

Johnson & Johnson had more revenue: $94.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025. Johnson & Johnson made a net profit of $26.8 B, while ProPhase Labs, Inc. made a net loss of $15 M.

Which is more profitable, Johnson & Johnson or ProPhase Labs, Inc.?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -339.6% for ProPhase Labs, Inc.

Which has more employees, Johnson & Johnson or ProPhase Labs, Inc.?

Johnson & Johnson employs more people: 138,200 against 19 at ProPhase Labs, Inc. Each employee brings in about $681,570 of revenue at Johnson & Johnson and $228,421 at ProPhase Labs, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.